Market Place
Sourcing Support
Galapagos Spinout Coultreon Raises $125M for SIK Program
28 Apr 2026 //
ENDPOINTS
Galapagos Took €228M Hit From Cell Therapy Wind-Down
24 Feb 2026 //
FIERCE BIOTECH
JPM26: Galapagos` New CEO Is Here To Finally Turn The Ship Around
19 Jan 2026 //
BIOSPACE
Galapagos Initiates Wind-Down Of Cell Therapy Operations
05 Jan 2026 //
GLOBENEWSWIRE
Galapagos` Last Immunology Asset Posts Mixed Results
19 Dec 2025 //
FIERCE BIOTECH
Galapagos Reveals Phase 3-Ready Data On TYK2 Inhibitor GLPG3667
18 Dec 2025 //
GLOBENEWSWIRE
Galapagos Unveils ATALANTA-1 Cell Therapy Data For MCL At ASH
08 Dec 2025 //
GLOBENEWSWIRE
Galapagos Urged By Gilead To Avoid Extinction
19 Nov 2025 //
FIERCE BIOTECH
Galapagos To Unveil Cell Therapy Program Data at ASH 2025
03 Nov 2025 //
GLOBENEWSWIRE
Galapagos To Showcase GLPG3667 Distinctiveness At ACR Convergence
23 Oct 2025 //
GLOBENEWSWIRE
Galapagos Exits Cell Therapy, Cuts 365 Employees
21 Oct 2025 //
BIOSPACE
Galapagos To Wind Down Cell Therapy Unit, Threatening 365 Jobs
21 Oct 2025 //
FIERCE BIOTECH
Galapagos Updates Strategic Options For Cell Therapy Unit
02 Oct 2025 //
PHARMAWEB
Galapagos Builds Island of Cell Therapies Amid Pipeline Pruning
24 Jul 2025 //
FIERCE BIOTECH
SEQENS CELLforCURE To Manufacture Galapagos CAR T Therapy
19 Jun 2025 //
PRESS RELEASE
Galapagos Shows Strong CAR-T Results in ICML 2025 Update
18 Jun 2025 //
GLOBENEWSWIRE
Galapagos to Present New ATALANTA-1 CAR-T Data at EHA 2025
12 Jun 2025 //
GLOBENEWSWIRE
Galapagos to Present GLPG5101 CAR-T Data at EHA & ICML 2025
14 May 2025 //
GLOBENEWSWIRE
Galapagos Reports Full Year 2024 Results & Provides Q4 Update
12 Feb 2025 //
GLOBENEWSWIRE
Catalent to Support Galapagos’ Decentralized CAR-T Therapy Trials
21 Jan 2025 //
CONTRACTPHARMA
Galapagos: CD19 CAR T Therapy Shows Promise in Non-Hodgkin Lymphoma
07 Dec 2024 //
#N/A
Galapagos Presents Cancer Cell Therapy Innovation at ASH 2024
05 Nov 2024 //
GLOBENEWSWIRE
Galapagos Welcomes Oleg Nodelman To Board Of Directors
07 Oct 2024 //
GLOBENEWSWIRE
Excellos to Support Galapagos’ CAR-T Cell Therapy Clinical Study
01 Oct 2024 //
CONTRACT PHARMA
Galapagos receives transparency notification from EcoR1 Capital
16 Sep 2024 //
GLOBENEWSWIRE
Galapagos pauses CAR-T cell therapy trial over Parkinsonism case
03 Aug 2024 //
FIERCE BIOTECH
Galapagos announces start of PAPILIO-1 Ph 1/2 multiple myeloma study of GLPG5301
19 Dec 2023 //
GLOBENEWSWIRE
Galapagos presents new encouraging data at ASH 2023 from GLPG5201 and GLPG5101
09 Dec 2023 //
GLOBENEWSWIRE
Galapagos presented efficacy data for CAR-T candidate, GLPG5201, in rrCLL
09 Feb 2023 //
GLOBENEWSWIRE
